Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges
Sonia Messina, Maria Sframeli
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2222-2222
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Spinal Muscular Atrophy: In the Challenge Lies a Solution
Brunhilde Wirth
Trends in Neurosciences (2021) Vol. 44, Iss. 4, pp. 306-322
Closed Access | Times Cited: 136
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry
Laurent Servais, John Day, Darryl C. De Vivo, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 425-442
Open Access | Times Cited: 26
Risdiplam: A Review in Spinal Muscular Atrophy
Julia Paik
CNS Drugs (2022) Vol. 36, Iss. 4, pp. 401-410
Open Access | Times Cited: 41
New therapies for spinal muscular atrophy: where we stand and what is next
Laura Antonaci, Maria Carmela Pera, Eugenio Mercuri
European Journal of Pediatrics (2023) Vol. 182, Iss. 7, pp. 2935-2942
Open Access | Times Cited: 27
Setting multidisciplinary intervention goals for spinal muscular atrophy patients utilizing the international classification of functioning, disability, and health: a pilot study in a small sample sizes
Gabriele Giannotta, Marta Ruggiero, Greta Pirani, et al.
Acta Neurologica Belgica (2025)
Open Access | Times Cited: 1
Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
Jan Lejman, Kinga Panuciak, Emilia Nowicka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1130-1130
Open Access | Times Cited: 22
hnRNP A/B Proteins: An Encyclopedic Assessment of Their Roles in Homeostasis and Disease
Patricia A. Thibault, Aravindhan Ganesan, Subha Kalyaanamoorthy, et al.
Biology (2021) Vol. 10, Iss. 8, pp. 712-712
Open Access | Times Cited: 36
Regenerative medicine: postnatal approaches
Paul Kwong Hang Tam, Kenneth Kak Yuen Wong, Anthony Atala, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 9, pp. 654-666
Open Access | Times Cited: 25
Biomarkers in 5q-associated spinal muscular atrophy—a narrative review
Hilmar Lapp, Maren Freigang, Tim Hagenacker, et al.
Journal of Neurology (2023) Vol. 270, Iss. 9, pp. 4157-4178
Open Access | Times Cited: 16
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study
Giorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 8
Open Access | Times Cited: 6
Gray and white matter abnormalities in children with type 2 and 3 SMA: A morphological assessment
Wanqing Shen, Zi Yan, Shu Su, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 3, pp. 1381-1388
Open Access | Times Cited: 5
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Sheridan M. Hoy
CNS Drugs (2021) Vol. 35, Iss. 12, pp. 1317-1328
Open Access | Times Cited: 31
RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
Zhichao Tang, Junxing Zhao, Zachary Pearson, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2263-2263
Open Access | Times Cited: 29
Changes in Ventilatory Support Requirements of Spinal Muscular Atrophy (SMA) Patients Post Gene-Based Therapies
Panagiota Panagiotou, Christina Kanaka‐Gantenbein, Athanasios G. Kaditis
Children (2022) Vol. 9, Iss. 8, pp. 1207-1207
Open Access | Times Cited: 21
History of development of the life-saving drug “Nusinersen” in spinal muscular atrophy
Jiaying Qiu, Liucheng Wu, Ruobing Qu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Early Development of Spinal Deformities in Children Severely Affected with Spinal Muscular Atrophy after Gene Therapy with Onasemnogene Abeparvovec—Preliminary Results
Venla Soini, Gudrun Schreiber, Bernd Wilken, et al.
Children (2023) Vol. 10, Iss. 6, pp. 998-998
Open Access | Times Cited: 13
MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA mice
Tai‐Heng Chen, Shih-Hsin Chang, Yu-Fu Wu, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 144-160
Open Access | Times Cited: 12
Molecular mechanisms of neuroprotective offerings by rosmarinic acid against neurodegenerative and other CNS pathologies
Pooja Ravaria, Priyanka Saxena, Shruti Laksmi BS, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 5, pp. 2119-2143
Closed Access | Times Cited: 12
Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy
Yuliya Voskobiynyk, Gopal Battu, Stephanie A. Felker, et al.
PLoS Genetics (2021) Vol. 17, Iss. 1, pp. e1009195-e1009195
Open Access | Times Cited: 25
Risdiplam for the Use of Spinal Muscular Atrophy
Juyeon Kakazu, Nakoma L. Walker, Katherine Claire Babin, et al.
Orthopedic Reviews (2021) Vol. 13, Iss. 2
Open Access | Times Cited: 24
Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1
Thiéry De Serres‐Bérard, Siham Ait Benichou, Dominic Jauvin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13359-13359
Open Access | Times Cited: 19
Leveraging Computational Intelligence Techniques for Diagnosing Degenerative Nerve Diseases: A Comprehensive Review, Open Challenges, and Future Research Directions
Saransh Bhachawat, Eashwar Shriram, Kathiravan Srinivasan, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 288-288
Open Access | Times Cited: 10
Late diagnosis of spinal muscular atrophy, primary symptoms of the disease according to the patient registry of the SMA Families Foundation
S. B. Artemyeva, Yu. О. Papina, O. Yu. Germanenko
Meditsinskiy sovet = Medical Council (2025), Iss. 22, pp. 80-86
Open Access
Spinal Muscular Atrophy (SMA): Treatment strategies, challenges and future prospects
Nikunja Kishor Mishra, Amiyakanta Mishra
Deleted Journal (2025), pp. 100031-100031
Closed Access
Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort
Ömer Bektaş, Murat Gülşen, Onur Burak Dursun, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top